The Nuclear Imaging Devices Market is estimated to be valued at USD 3.2 billion in 2025 and is projected to reach USD 5.1 billion by 2035, registering a compound annual growth rate (CAGR) of 5.0% over the forecast period.
| Metric | Value |
|---|---|
| Nuclear Imaging Devices Market Estimated Value in (2025 E) | USD 3.2 billion |
| Nuclear Imaging Devices Market Forecast Value in (2035 F) | USD 5.1 billion |
| Forecast CAGR (2025 to 2035) | 5.0% |
The nuclear imaging devices market is gaining strong momentum, driven by the rising prevalence of chronic diseases and the increasing demand for advanced diagnostic imaging solutions. Adoption is being supported by the expanding role of molecular imaging in early disease detection, treatment planning, and monitoring therapeutic response. Continuous advancements in detector technology, radiopharmaceutical development, and hybrid imaging systems are significantly improving diagnostic accuracy and patient outcomes.
The ability to provide functional insights at a molecular level, beyond anatomical imaging, is reinforcing the value of nuclear imaging devices in modern healthcare systems. Growing investment in oncology research, cardiology diagnostics, and neurological studies is further fueling demand.
Healthcare infrastructure development in emerging markets and favorable reimbursement frameworks in developed economies are also influencing adoption positively As the medical community emphasizes precision medicine and personalized treatment strategies, nuclear imaging devices are expected to remain central in supporting early diagnosis and effective disease management, positioning the market for long-term expansion across global healthcare settings.
The nuclear imaging devices market is segmented by technique, application, and geographic regions. By technique, nuclear imaging devices market is divided into Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT), Planar Scintigraphy, and Hybrid Imaging. In terms of application, nuclear imaging devices market is classified into Cancer, Cardiology, Infection and Inflammation, and Neurology. Regionally, the nuclear imaging devices industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The positron emission tomography segment is expected to account for 29.3% of the nuclear imaging devices market revenue share in 2025, making it the leading technique. This leadership is being reinforced by its high sensitivity in detecting metabolic changes and disease progression at an early stage, which supports timely clinical intervention. PET is particularly valued for its ability to provide comprehensive imaging of cellular activity, enabling superior accuracy in disease localization and treatment monitoring.
Continuous advancements in scanner resolution, time-of-flight technology, and the integration of PET with computed tomography and magnetic resonance imaging are further improving diagnostic precision. The segment’s growth is being driven by its broad clinical applications in oncology, cardiology, and neurology, which require functional imaging for accurate patient management.
Expanding production and distribution of novel radiopharmaceuticals is supporting wider accessibility and utilization of PET imaging As healthcare providers increasingly adopt personalized medicine approaches, PET is positioned to maintain its market leadership due to its indispensable role in guiding clinical decision-making and improving patient outcomes.
The cancer application segment is projected to represent 41.2% of the nuclear imaging devices market revenue share in 2025, making it the leading application area. Its dominance is being supported by the rising global burden of cancer and the growing emphasis on early detection and treatment optimization. Nuclear imaging devices are playing a pivotal role in identifying malignant tumors, staging cancers, evaluating therapeutic responses, and monitoring recurrence with high precision.
The functional imaging capabilities offered by these devices provide insights into tumor metabolism and proliferation, which cannot be captured by conventional anatomical imaging alone. Increasing investments in oncology research and the development of targeted radiopharmaceuticals are further strengthening the clinical utility of nuclear imaging in cancer management.
Healthcare providers are prioritizing these technologies for their ability to improve diagnostic confidence and patient survival rates As cancer incidence continues to rise worldwide, nuclear imaging devices are expected to remain the cornerstone of advanced diagnostic pathways, ensuring sustained growth for this application segment.
Sales of nuclear imaging devices are expected to rise due to advancements in radiotracers with the transition from solo to hybrid methods. In addition to this, demand for nuclear imaging devices is rising on account of investments in diagnostic imaging centers through public-private partnerships and the rising incidence and prevalence of cancer and heart disease.
Increasing focus on personalized medicine is also projected to contribute to the growth of the nuclear imaging devices market share.
The report sheds light on the factors improving the sales of nuclear imaging devices, and, in turn, the opportunities for the market players. However, the nuclear imaging devices market also faces some challenges, which might limit thenuclear imaging devices market share from reaching its potential.
Some of the key nuclear imaging devices market trends promoting the demand for nuclear imaging devices include the major evolution of hybrid systems due to technological advancements in the field of imaging. In comparison to solo systems, hybrid systems can deliver more exact images with higher resolution. They can provide both morphological and physiological data in a single evaluation. In the case of skeletal examination, for example, a SPECT/CT system provides accurate localization while also enhancing the specificity of CT information.
Many hospitals are now replacing standalone systems with hybrid systems due to benefits like these. The nuclear imaging equipment market is expected to rise due to the growing popularity of hybrid modalities.
Ageing population, increase prevalence of disease such as cancer, technological advancement, innovation, rising patient awareness, increasing healthcare expenditure, new imaging agents, increasing demand for cancer diagnostic tests, are the most important driving factors in the sales of nuclear imaging devices. Since nuclear imaging devices have high importance in medical imaging techniques, the demand for nuclear imaging devices has increased.
Nuclear Imaging is the branch of medical imaging that uses radioactive material to diagnose the severity of the diseases such as cancer, cardiovascular disease, gastrointestinal, endocrine, neurological disorders and other abnormalities within the body.
Nuclear imaging procedures are non-invasive and painless medical tests that help physicians diagnose and evaluate medical conditions, thus leading to a rise in sales of nuclear imaging devices.
With so many advantages of nuclear imaging devices, it has few disadvantages too. Insurance company lobbying to reduce unnecessary changing, reimbursement legislation, greater payer scrutiny of EMRs, loss of nuclear medicine skills, high cost of instruments, supply difficulties and cost of radiopharmaceutical, medical device excise tax are acting as a barrier to the demand for nuclear imaging devices.
Thesales of nuclear imaging devices have grown substantially at a healthy CAGR due to growing ageing population and increasing prevalence of diseases. With rapid technological advancement and innovation, the nuclear imaging devices market is expected to grow globally. Asia Pacific would be the fastest growing market in the forecast period due to increase advancement in neurological applications, improving healthcare infrastructure and rapid economic growth.
The nuclear imaging devices market is expected to register a modest CAGR for the forecast period.
Depending on geographic regions, thedemand for nuclear imaging devices is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.
North America has the largest market for the sales of nuclear imaging devices and is contributing the most as compared to other regions. The Asia Pacific and Japan are the fastest-growing region in the forecast period for thesales of nuclear imaging devices.
Nuclear imaging is a fiercely competitive business with only a few large competitors driving the sales of nuclear imaging devices.
Few big firms currently dominate the market in terms of demand for nuclear imaging devices. The nuclear imaging devices market is dominated by companies such as Bracco Imaging SpA, Curium, Cardinal Health Inc., Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers, among others.
Various market developments have recently occurred which have impacted thesales of nuclear imaging devices, such as Curium's acquisition of Cyclopharma's French commercial and production activities in May 2025, which strengthened Curium's position in the French PET market by catering to the strongdemand for nuclear imaging devices.
The report consists of key players contributing to thenuclear imaging devices market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions.
This exclusive report analyses the competitive landscape and nuclear imaging devices market share acquired by players to strengthen their market position.
| Country | CAGR |
|---|---|
| China | 6.8% |
| India | 6.3% |
| Germany | 5.8% |
| France | 5.3% |
| UK | 4.8% |
| USA | 4.3% |
| Brazil | 3.8% |
The Nuclear Imaging Devices Market is expected to register a CAGR of 5.0% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 6.8%, followed by India at 6.3%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 3.8%, yet still underscores a broadly positive trajectory for the global Nuclear Imaging Devices Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 5.8%. The USA Nuclear Imaging Devices Market is estimated to be valued at USD 1.1 billion in 2025 and is anticipated to reach a valuation of USD 1.7 billion by 2035. Sales are projected to rise at a CAGR of 4.3% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 172.7 million and USD 105.5 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 3.2 Billion |
| Technique | Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT), Planar Scintigraphy, and Hybrid Imaging |
| Application | Cancer, Cardiology, Infection and Inflammation, and Neurology |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | CMR Naviscan, GE Healthcare, Digirad, SurgicEye, Siemens Healthcare, Nucare Medical System, GVI Medical Devices, Neurologica, Shimadzu, Philips Healthcare, CardiArc, and DDD-diagnostic |
The global nuclear imaging devices market is estimated to be valued at USD 3.2 billion in 2025.
The market size for the nuclear imaging devices market is projected to reach USD 5.1 billion by 2035.
The nuclear imaging devices market is expected to grow at a 5.0% CAGR between 2025 and 2035.
The key product types in nuclear imaging devices market are positron emission tomography (pet), single-photon emission computed tomography (spect), planar scintigraphy and hybrid imaging.
In terms of application, cancer segment to command 41.2% share in the nuclear imaging devices market in 2025.
Explore Similar Insights
Nuclear Imaging Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
